CancerCare Announces Funding for Multiple Myeloma Patients Through CancerCare Co-Payment Assistance Foundation (CCAF)
CancerCare is pleased to announce the availability of co-payment assistance for people diagnosed with multiple myeloma through the CancerCare Co-Payment Assistance Foundation.
NEW YORK, NY (January 25, 2016) — CancerCare is pleased to announce the availability of co-payment assistance for people diagnosed with multiple myeloma through the CancerCare Co-Payment Assistance Foundation. CancerCare is the leading national nonprofit organization providing free, professional support services to anyone affected by cancer.
The CancerCare Co-Payment Assistance Foundation (CCAF) is dedicated to helping people with cancer meet what otherwise are significant co-payment obligations for cancer treatment. CCAF is authorized to provide co-payment assistance for all types of cancer. This assistance is provided to ensure that patients have access to care and prescribed treatments.
People receiving assistance from CCAF also have immediate, ongoing access to the full array of CancerCare services, including counseling, support groups (online, telephone and in-person), resource referrals, publications, education and financial assistance with treatment-related expenses such as transportation and child care. The robust network of support services offered by CancerCare can have a significant impact on the patient, as well as the entire family.
“We are thrilled to provide this crucial co-payment assistance to people coping with multiple myeloma,” said Patricia J. Goldsmith, CancerCare Chief Executive Officer. “Many new treatments for multiple myeloma have become available over the past two decades, and the CancerCare Co-Payment Assistance Foundation is committed to helping patients access the care they need so that they can focus on managing their diagnosis and maintaining quality of life during treatment.”
The American Cancer Society estimates that over 30,000 individuals will be newly diagnosed with multiple myeloma, a cancer of the bone marrow, in 2016. This funding will enable CCAF to continue providing much-needed, comprehensive assistance to patients who are struggling to meet their coinsurance obligations, which may enable them to adhere to their prescribed treatments and potentially help to improve their outcomes.
To qualify for assistance, patients diagnosed with multiple myeloma must meet certain financial and insurance criteria. For more information, or to apply for assistance, patients and healthcare professionals can visit the CCAF website, www.cancercarecopay.org, or call 866-55-COPAY (866-552-6729). CCAF’s Co-Payment Specialists are available to take calls Monday through Thursday from 9 a.m. to 7 p.m. EST, and Friday from 9 a.m. to 5 p.m. EST.